ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 615804 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 615804; 2) Community: the network communities that were significantly associated with the response to NSC 615804; 3) Molecule: the relationships between components within communities and NSC 615804; 4) MDR: the compounds that were significantly associated with the NSC 615804.

NSC Compound Enrichment Correlation
NSC 744579 6,7-Difluoro-3-methyl-1,4-dioxyquinoxaline-2-carboxylic acid 4-methoxybenzylamide 0.045446901295916 0.078883016
NSC 744633 Null 0.045446901295916 0.13453391
NSC 745062 Null 0.045446901295916 0.23994863
NSC 754081 7-(4-methoxybenzyl)-4,4-dimethyl-6-phenyl-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole 0.045446901295916 0.15810239
NSC 754240 2,9-dimethoxy-6-(2-(piperidin-1-yl)ethoxy)-11H-indeno[1,2-c]quinolin-11-one 0.045446901295916 0.39769459
NSC 77810 Naphtho[1,2-b]quinolizinium, 9-methyl-, bromide 0.045446901295916 -0.018758274
NSC 96541 Benzo[f]quinoline-3-carbonitrile, 4-benzoyl-3,4-dihydro- (8CI9CI) 0.045446901295916 0.26813051
NSC 116878 Cardiac glycoside 0.0454469012959173 0.031605487
NSC 123978 Sarveroside 0.0454469012959173 0.088001877
NSC 133072 Ethanesulfonic acid, compd. with 4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)-m-hydrocinnamotoluidide (1:1) 0.0454469012959173 0.3213215
Total:60  Current:52    [First] [Prev] [Next] [Last]